Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened ...

After an FDA warning, Medtronic has recalled two of its MiniMed insulin pump products that could be wirelessly interfered with by hackers. Medtronic thinks there’s no evidence that anyone using ...

Medtronic Plc announced a voluntary ... notifying global customers of its MiniMed 600 series or 700 series insulin pumps to ...

Medtronic's MiniMed 670G - the closest thing yet to ... system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device ...

Medtronic has introduced many technology breakthroughs that brings us closer to our end vision: the closed loop system. Using this experience we have developed the MiniMed Veo Insulin pump. 1.

Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.

With a new smartphone app clearance from the FDA, Medtronic said it has all the pieces necessary to deliver a complete ...

George Alternatively, to learn more about insulin pump therapy please visit medtronic-diabetes.co.uk. Speak to your Healthcare Professional (HCP) for more information. At no point should this be seen ...

The InPen app paves the way for the launch of the company’s “Smart MDI” system combining a smart insulin pen that tracks ...

The company also initiated a voluntary field action for its MiniMed™ 600 and 700 series insulin pumps due to potential battery issues. RBC Capital Markets upgraded Medtronic's rating from Sector ...